Product Information
LURASIDONE HCL 120 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.4867 per EA under NDC 76282052530. Its NADAC has been published 151 times since Nov 15, 2023.
FDA first approved this application on Jan 3, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
120 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282052530
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LURASIDONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208028FDA Approved
1/3/2019
TE Code
AB
On Market Since
2/20/2023
Pharmacological Classes
Price Statistics
The NADAC for LURASIDONE HCL 120 MG TABLET has been published 151 times since Nov 15, 2023, and over the history we have for it it has declined 34.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4867 per EA |
|---|---|
| All-time high | $0.8059 (Sep 11, 2024) |
| All-time low | $0.4824 (Aug 19, 2026) |
| 52-week high | $0.6838 |
| 52-week low | $0.4824 |
| Median price | $0.6380 |
| Average price | $0.6311 |
| Largest weekly change | +32.6% (Aug 21, 2024) |
| Weeks tracked | 151 |
| Tracking since | Nov 15, 2023 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lurasidone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LURASIDONE HCL 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LURASIDONE HCL 120 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.4867 per EA (NDC 76282052530), effective Sep 30, 2026.
How has the price of LURASIDONE HCL 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for LURASIDONE HCL 120 MG TABLET has declined 34.3%. It has been tracked across 151 weekly CMS publications since Nov 15, 2023.
What are the highest and lowest recorded NADAC prices for LURASIDONE HCL 120 MG TABLET?
Since Nov 15, 2023, the NADAC for LURASIDONE HCL 120 MG TABLET has ranged from a low of $0.4824 (Aug 19, 2026) to a high of $0.8059 (Sep 11, 2024), with a median of $0.6380 per EA.
Are there cheaper alternatives to LURASIDONE HCL 120 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LURASIDONE HCL 120 MG TABLET, is $0.4824 per EA — about 1% below LURASIDONE HCL 120 MG TABLET.
Who manufactures LURASIDONE HCL 120 MG TABLET?
LURASIDONE HCL 120 MG TABLET (NDC 76282052530) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.